BLOG: Abiraterone should continue to be available on the NHS and opened up to all men with newly diagnosed advanced prostated cancer, argues our policy manager Tim Windle, as the UK’s drug guidelines body is set to rule on the future of the treatment.
An early-stage trial of the immunotherapy drug, pembrolizumab, has proven it to be effective for a small number of men with incurable disease. We take a closer a look at how it works and what we're doing to bring the benefits of immunotherapy to many more men with prostate cancer.
Hormone therapy is a treatment that controls rather than cures prostate cancer that has spread, so we’re often asked what’s next if it stops working so well. Our Specialist Nurse, Patricia, looks at the options.
This week the PSA test is in the media spotlight after results from a large prostate cancer trial were released. So what should men do if they are worried about prostate cancer? Who should have a PSA test? Our Specialist Nurse, Ali Rooke sets out the facts.
Our Specialist Nurses received record numbers of enquiries last week after prostate cancer dominated the headlines. So we've pulled together their answers to the most commonly asked questions, as well as footage of our recent Facebook Live Q&A event, to give everyone the lowdown on the UK's third biggest cancer killer.
BLOG: Angela Culhane, our CEO, discusses in further detail the reasons behind this change in figures announced last week.
For the first time, more men are dying from prostate cancer each year than women are from breast cancer, making the male disease the third biggest cancer killer in the UK. We find out why and urge the public to March for Men with us this summer to help curb the trend.
After we investigated complaints from men unable to get hold of the off-patent prostate cancer drug, bicalutamide, the British Generic Manufacturers' Association has told us problems with supply shouldn't last long.
The festive period takes it out of us all, but when you have cancer it can be even harder to bounce back. Around three quarters of men with prostate cancer will experience fatigue (extreme tiredness) at some point. Normal tiredness gets better once you’ve rested, but for some, fatigue can be a debilitating problem that has a dramatic impact on quality of life. However, you don’t have to simply accept this.
A report released by the Royal College of Surgeons shows more men are getting an appropriate level of treatment, but issues with late diagnosis persist and uptake of mpMRI has been patchy. However, a pilot scheme also announced today offers a promising step forward.